Kalytera Will Not Proceed with Vote on Potential Share Consolidation
July 26, 2019 18:01 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, July 26, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera”) announced today that after...
Kalytera Announces Completion of Food Effect and QTc Study
July 16, 2019 08:30 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
Kalytera to Acquire CBD Extraction Business
June 27, 2019 08:30 ET
|
Kalytera Therapeutics Inc.
Business Will Be Amongst Largest Such Operations in U.S. Transaction Will Provide Near-Term Path to Revenues SAN FRANCISCO and TEL AVIV, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Kalytera...
Kalytera Provides Update on GVHD Program
June 25, 2019 09:54 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO AND TEL AVIV, Israel, June 25, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today provided an update on its...
Kalytera Announces Changes to Board of Directors
June 21, 2019 10:00 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, June 21, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced changes to the...
Kalytera Announces Additional Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
June 18, 2019 08:30 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, June 18, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
Kalytera Reports First Quarter 2019 Financial Results
May 31, 2019 08:30 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, May 31, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today reported financial results...
Kalytera Announces Submission of Patent Application to the U.S. Patent and Trademark Office
May 29, 2019 08:30 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, ISRAEL, May 29, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has filed a...
Kalytera Announces Data Further Elucidating CBD’s Mechanisms of Action in Prevention of GVHD
May 28, 2019 08:30 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced new laboratory...
Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products
May 21, 2019 16:42 ET
|
Kalytera Therapeutics Inc.
SAN FRANCISCO and TEL AVIV, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") has engaged Echelon Wealth Partners...